Last reviewed · How we verify
NCT04829227
Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
Phase 3 trial testing Sofwave in Skin Laxity in 45 participants. Completed in 31 December 2021.
31 December 2021
Quick facts
| Lead sponsor | Sofwave Medical LTD |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 10 January 2020 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Sofwave
Conditions studied
- Skin Laxity — all drugs for Skin Laxity →
Sponsor
Sofwave Medical LTD
Who can join
Adults 35 to 80, any sex, with Skin Laxity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open-label, non-randomized 2 arms prospective, multi-center, self-controlled clinical study with masked evaluation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04829227
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sofwave
Trials testing the same drug.
- NCT07342452 — Randomized Trial of Combination Treatment With Sofwave and Sculptra · Phase 4 · not yet recruiting
- NCT06333067 — Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators · NA · recruiting
- NCT06104514 — Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids · NA · completed
- NCT05882721 — Treatment for Improvement of Cellulite Appearance Using Form Applicator · NA · completed
- NCT05358327 — Treatment for Lifting Upper Arm Lax Skin · NA · completed
Other recruiting trials for Skin Laxity
Currently open trials in the same condition.
- NCT07224880 — Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 R · recruiting
- NCT06941610 — An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity · NA · recruiting
- NCT06724510 — Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting · NA · recruiting
- NCT06603194 — Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults · NA · recruiting
- NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting
Other Sofwave Medical LTD trials
Trials by the same sponsor.
- NCT07094971 — Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles · NA · recruiting
- NCT06724146 — Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance · NA · active not recruiting
- NCT06333067 — Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators · NA · recruiting
- NCT06104514 — Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids · NA · completed
- NCT05882721 — Treatment for Improvement of Cellulite Appearance Using Form Applicator · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04829227 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sofwave Medical LTD
- Last refreshed: 26 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04829227.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing